Guidant Cites Ethics In Countering Drug-Eluting Stent Data Enjoinment
This article was originally published in The Gray Sheet
Executive SummaryGuidant is relying on two ethical arguments to persuade a federal judge not to block access to clinical drug-eluting stent data collected in collaboration with Cook, Inc
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.